公司资料
Avidity Biosciences 股价、新闻与催化剂
- 股票代码:
- RNA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
12.96 USD (+0.93%)
收盘价
最后更新: 2026年8月17日
210M USD
市值
股价为何变动
As of Aug 17, 2026, RNA closed up 0.93% at $12.96. No new same-company headline was identified in the current news window.
公司概览
业务概览
Avidity Biosciences is an RNA-targeting company focused on delivering therapies to muscle and other tissues using its antibody oligo conjugate platform. Its story is built around targeted RNA delivery and disease-specific programs.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Avidity sits in advanced biotechnology.
商业模式特征
The company depends on platform validation, clinical data, and the promise of targeted RNA delivery to hard-to-reach tissues.
生物医药行业定位
Avidity is one of the most interesting RNA-delivery names because platform success could unlock multiple disease areas.
未来催化剂
- Avidity Biosciences's catalysts are AOC 1001 and the rest of its muscle-disease programs, where human data keep validating the delivery platform. The market will care about whether the platform keeps producing convincing in-human signals.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。